Vect-Horus
PrivateLast Round
Series D
Jan 20, 2021
Total Funding Raised
$14.34M
Company Overview
Vect-Horus operates in Healthcare & Life Sciences and is based in Marseille. Its latest recorded funding round was a Series D round in January 2021.
Vect-Horus is a biotechnology company that develops a targeted drug delivery system intended to enhance the transport of biotherapeutics across biological barriers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Medical Imaging
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vect-Horus Comparables
Compare Vect-Horus with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ossianix | 81% | |
| Gate2Brain | 81% | |
| ABL Bio, Inc. | 77% |
For institutional investors. Book with your work email.
Vect-Horus Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Jan 20, 2021 | ||||
| VC Round | Jun 7, 2018 | ||||
| VC Round | Mar 22, 2017 | ||||
| VC Round | Dec 15, 2014 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Vect-Horus Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CAAP Création | VC Round |
| SCR Provençale et Corse | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 16, 2026
Monthly visitors grew 103% MoM, reaching 1.2K.
- Feb 18, 2026
Grew 24% QoQ, from 41 to 51 employees.
For institutional investors. Book with your work email.
Vect-Horus Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Vect-Horus's valuation, stock price, and market status.
Is Vect-Horus a public or private company?
Vect-Horus is a private company.
What is the current stock price of Vect-Horus?
Vect-Horus is a private company, so its shares have no public market price. Caplight tracks Vect-Horus's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Vect-Horus worth (valuation)?
Valuation information for Vect-Horus is not publicly available.
Can I buy Vect-Horus stock?
Vect-Horus shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Vect-Horus's last funding round?
Vect-Horus's most recent funding round was Series D on January 20, 2021.
Who are the main investors in Vect-Horus?
Key investors in Vect-Horus include CAAP Création, SCR Provençale et Corse.
Will Vect-Horus IPO soon?
No public IPO plans have been announced for Vect-Horus.
How can I track Vect-Horus secondary market activity?
Caplight tracks bids, offers, and trades in Vect-Horus's shares on secondary markets.